ASX-listed soft tissue regeneration company Aroa released the first results from its ongoing prospective study into its Myriad product just two days before Christmas.
Given the hustle and bustle prior to year’s end and the announcement’s accurate though unsexy heading ‘Study demonstrates
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
